Red X iconGreen tick iconYellow tick icon

Contact Details

Postdoctoral Research Fellow
Department of Physiology
BSc MSc and PhD in Pharmaceutical Biology
Research summary
Role of microRNAS in diabetic ulcer


To develop a biodegradable patch for the treatment of chronic non-healing diabetic ulcer.


Fan, C., Eedara, B. B., Sinha, S., Udden, M. K. M., Doyle, C., Banu, S., & Das, S. C. (2024). Triple combination dry powder formulation of pretomanid, moxifloxacin, and pyrazinamide for treatment of multidrug-resistant tuberculosis. International Journal of Pharmaceutics, 654, 123874. doi: 10.1016/j.ijpharm.2024.123984 Journal - Research Article

Das, S. C., Khadka, P., Sinha, S., Katare, R., Hill, P. C., & Dummer, J. (2023). Towards the clinical translation of inhaled rifampicin for tuberculosis. In R. N. Dalby, J. Peart, D. Traini, P. M. Young & J. D. Suman (Eds.), Respiratory drug delivery. 2023, (pp. 11-18). Richmond, VA: RDD Online. [Full Paper] Conference Contribution - Published proceedings: Full paper

Saha, T., Sinha, S., Harfoot, R., Quiñones‑Mateu, M. E., & Das, S. C. (2023). Development of inhalable dry powders combining replication and protease inhibitors of SARS-CoV-2. Proceedings of the 34th Drug Delivery to the Lungs (DDL) Conference. 34, (pp. 389-392). Retrieved from Conference Contribution - Published proceedings: Full paper

Eedara, B. B., Fan, C., Sinha, S., Khadka, P., & Das, S. C. (2023). Inhalable combination powder formulations for treating latent and multidrug-resistant tuberculosis: Formulation and in vitro characterization. Pharmaceutics, 15, 2354. doi: 10.3390/pharmaceutics15092354 Journal - Research Article

Saha, T., Sinha, S., Harfoot, R., Quiñones‑Mateu, M. E., & Das, S. C. (2023). Inhalable dry powder containing remdesivir and disulfiram: Preparation and in vitro characterization. International Journal of Pharmaceutics, 645, 123411. doi: 10.1016/j.ijpharm.2023.123411 Journal - Research Article

Back to top